FOXP3型
医学
肾细胞癌
无容量
内科学
CD8型
肿瘤科
免疫系统
白细胞介素2受体
肾切除术
肿瘤坏死因子α
肿瘤浸润淋巴细胞
干扰素γ
T细胞
免疫疗法
癌症
肾
免疫学
细胞因子
作者
Onur Yazdan Balçık,David Akin,Gülay Ceylan,Bilgin Demir,A Aytaç,Nil Çulhacı,Esin Oktay
出处
期刊:PubMed
日期:2023-08-01
卷期号:27 (16): 7781-7792
被引量:1
标识
DOI:10.26355/eurrev_202308_33433
摘要
In patients with metastatic RCC, higher GITR was associated with better PFS. At the same time, in patients using nivolumab, better PFS was seen in the GITR high group. If supported by prospective studies, GITR can be used as both a prognostic and predictive marker.
科研通智能强力驱动
Strongly Powered by AbleSci AI